Skip to main content

The Contribution of Non-Dopaminergic Pathology to Cognitive, Motor and Affective Disability in Parkinson’s Disease

  • Chapter
Alzheimer’s and Parkinson’s Diseases

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 44))

Abstract

Cognitive deficits in Parkinson’s disease (PD) are now well recognised although the pathophysiological basis of the deficits remains uncertain (reviewed by Brown and Marsden, 1988; Sagar and Sullivan, 1988). The cognitive deficits occur particularly on “executive” tasks, which are known to be sensitive to frontal lobe dysfunction raising the possibility that a frontal lobe disorder is the basis of the majority of the cognitive impairment in the disease. The pathogenesis of the cognitive deficits remains uncertain but most investigators have concentrated on the role of the “complex” loop between the caudate nucleus and prefrontal cortex (De Long et al., 1984). A deficiency of caudate dopamine is regarded as the principal cause of dysfunction within this loop. Another contributing factor may be dopamine deficiency in the ventral tegmental area leading to dysfunction in the mesocortical projections to the frontal cortex (Javoy-Agid and Agid, 1980; Sagar, 1985).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agid Y., Ruberg M., Dubois B., and Javoy-Agid F., 1984, Biochemical substrates of mental disturbances in Parkinson’s disease, Adv. Neurol. 40: 211–218.

    PubMed  CAS  Google Scholar 

  • Brown R., and Marsden C.D., 1988, Subcortical dementia: the neuropsychological evidence, Neuroscience 25: 363–387.

    Article  PubMed  CAS  Google Scholar 

  • Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., and Sullivan E.V., 1991, Cognitive impairment in early untreated Parkinson’s disease and its relationship to motor disability, Brain 114: 2095–2122.

    Article  PubMed  Google Scholar 

  • Cooper J.A., Sagar H.J., Doherty S.M., Jordan N., Tidswell P., and Sullivan E.V., 1992, Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson’s disease: a follow-up study of untreated patients, Brain 115: 1701–1725.

    Article  PubMed  Google Scholar 

  • Cooper J.A., Sagar H.J., Tidswell P. and Jordan N. Slowed cognitive processing on simple and go/no-go reaction time tasks in Parkinson’s disease, Brain, in press.

    Google Scholar 

  • De Long M.R., Georgopoulos A.P., Crutcher M.D., Mitchell S.J., Richardson R.T., and Alexander G.E., 1984, Functional organization of the basal ganglia: contributions of single-cell recordings, in: “Functions of the Basal Ganglia”, Ciba Foundation Symposium 107, D. Evered and M. O’Connor, eds., Pitman, London, pp 64–82.

    Google Scholar 

  • Dubois B., Danze F., Pillon B., Cusimano G., Lhermitte F., and Agid Y., 1987, Cholinergic-dependent cognitive deficits in Parkinson’s disease, Ann. Neurol. 22: 26–30.

    Article  PubMed  CAS  Google Scholar 

  • Fibiger H.C., 1984, The neurobiological substrates of depression in Parkinson’s disease: a hypothesis. Can. J. Neurol. Sci. 11: 105–107.

    PubMed  CAS  Google Scholar 

  • Javoy-Agid F., and Agid Y., 1980, Is the mesocortical dopamine system involved in Parkinson disease? Neurology, New York 30: 1326–1330.

    CAS  Google Scholar 

  • Lange K.W., Robbins T.W., Marsden C.D., James M., Owen A.M., and Paul G.M., 1992, L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology (Berl), 107: 394–404.

    CAS  Google Scholar 

  • Mayeux R., Stern Y., Cote, L., and Williams J.B.W., 1984, Altered serotonin metabolism in depressed patients with Parkinson’s disease, Neurology 34: 642–646.

    Article  PubMed  CAS  Google Scholar 

  • Pillon B., Dubois B., Cusimano G., Bonnet A., Lhermitte F., and Agid Y.,1989, Does cognitive impairment in Parkinson’s disease result from non-dopaminergic lesions? J. Neurol. Neurosurg. Psychiatry 52: 201–206

    Google Scholar 

  • Rogers D., Lees A.J., Smith E., Trimble M., and Stern G.M., 1987, Bradyphrenia in Parkinson’s disease and psychomotor retardation in depressive illness, Brain, 110: 761–776.

    Article  PubMed  Google Scholar 

  • Sagar H.J., 1985, Brain-behavior relationships in amnesia and dementia, in: “Senile dementia of the Alzheimer type”, J.T. Hutton, A.D. Kenny AD, eds., Alan R Liss, New York, pp 87–104.

    Google Scholar 

  • Sagar H.J. and Sullivan E.V., 1988, Patterns of cognitive impairment in dementia, in: “Recent Advances in Clinical Neurology”, Vol. 5, C. Kennard, ed, Churchill Livingstone, Edinburgh, p 47–86.

    Google Scholar 

  • Sagar H.J., Sullivan E.V., Gabrieli J.D.E., Corkin S., and Growdon J.H., 1988, Temporal ordering and short-term memory deficits in Parkinson’s disease, Brain 111: 525–539.

    Article  PubMed  Google Scholar 

  • Stern Y., Mayeux R., and Cote L., 1984, Reaction time and vigilance in Parkinson’s disease: possible role of altered norepinephrine metabolism, Arch. Neurol. 41: 1086–1089

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sagar, H.J., Atchison, L., Doherty, S.M., Ball, M.C., Cooper, J.A. (1995). The Contribution of Non-Dopaminergic Pathology to Cognitive, Motor and Affective Disability in Parkinson’s Disease. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9145-7_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9147-1

  • Online ISBN: 978-1-4757-9145-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics